期刊
ONCOGENE
卷 41, 期 19, 页码 2734-2748出版社
SPRINGERNATURE
DOI: 10.1038/s41388-022-02293-y
关键词
-
资金
- Science and Technology Development Fund, Macau SAR [FDCT/0107/2020/A, FDCT/0030/2020/A]
- Multi-Year Research Grant, University of Macau [MYRG2019-00116-FHS, MYRG2020-00229-FHS]
SMAD4 loss is frequently observed in colorectal cancer and represents a potential drug target. This study identifies a synthetic lethal interaction between SMAD4 and AURKA, showing that AURKA inhibition selectively inhibits the growth of SMAD4-deficient CRC cells by inducing cell cycle delay and apoptosis. The study also reveals that SMAD4-deficient CRC cells are hyper-dependent on AURKA activity for mitotic exit and survival during SAC hyperactivation.
SMAD4 loss-of-function mutations have been frequently observed in colorectal cancer (CRC) and are recognized as a drug target for therapeutic exploitation. In this study, we performed a synthetic lethal drug screening with SMAD4-isogenic CRC cells and found that aurora kinase A (AURKA) inhibition is synthetic lethal with SMAD4 loss. Inhibition of AURKA selectively inhibited the growth of SMAD4(-/-) CRC in vitro and in vivo. Mechanistically, SMAD4 negatively regulated AURKA level, resulting in the significant elevation of AURKA in SMAD4(-/-) CRC cells. Inhibition of AURKA induced G(2)/M cell cycle delay in SMAD4(+/+) CRC cells, but induced apoptosis in SMAD4(-/-) CRC cells. We further observed that a high level of AURKA in SMAD4(-/-) CRC cells led to abnormal mitotic spindles, leading to cellular aneuploidy. Moreover, SMAD4(-/-) CRC cells expressed high levels of spindle assembly checkpoint (SAC) proteins, suggesting the hyperactivation of SAC. The silencing of key SAC proteins significantly rescued the AURKA inhibition-induced cell death in SMAD4(-/-) cells, suggesting that SMAD4(-/-) CRC cells are hyper-dependent on AURKA activity for mitotic exit and survival during SAC hyperactivation. This study presents a unique synthetic lethal interaction between SMAD4 and AURKA and suggests that AURKA could be a potential drug target in SMAD4-deficient CRC.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据